Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 9 | 2022 | 427 | 1.100 |
Why?
|
| Surgeons | 5 | 2025 | 161 | 0.810 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2011 | 12 | 0.730 |
Why?
|
| Braces | 2 | 2014 | 10 | 0.710 |
Why?
|
| Hospitals | 2 | 2023 | 378 | 0.660 |
Why?
|
| Intestinal Obstruction | 3 | 2012 | 49 | 0.640 |
Why?
|
| Child | 28 | 2025 | 4189 | 0.630 |
Why?
|
| Urinary Tract Infections | 2 | 2011 | 80 | 0.600 |
Why?
|
| Appendicitis | 3 | 2018 | 74 | 0.570 |
Why?
|
| Child, Preschool | 17 | 2025 | 1793 | 0.540 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.450 |
Why?
|
| Infant | 15 | 2025 | 1492 | 0.440 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 19 | 0.400 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 33 | 0.390 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 275 | 0.380 |
Why?
|
| Bites and Stings | 1 | 2011 | 11 | 0.380 |
Why?
|
| Facial Injuries | 1 | 2011 | 13 | 0.370 |
Why?
|
| Cicatrix | 2 | 2011 | 59 | 0.370 |
Why?
|
| Specialties, Surgical | 2 | 2023 | 45 | 0.370 |
Why?
|
| Wound Infection | 1 | 2011 | 26 | 0.370 |
Why?
|
| Treatment Outcome | 14 | 2025 | 5283 | 0.370 |
Why?
|
| Adolescent | 20 | 2025 | 5838 | 0.360 |
Why?
|
| Colectomy | 1 | 2012 | 104 | 0.360 |
Why?
|
| Humans | 53 | 2025 | 59389 | 0.360 |
Why?
|
| Dextrans | 2 | 2009 | 45 | 0.360 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 66 | 0.350 |
Why?
|
| Hyaluronic Acid | 2 | 2009 | 66 | 0.340 |
Why?
|
| Dogs | 1 | 2011 | 314 | 0.340 |
Why?
|
| Retrospective Studies | 16 | 2025 | 6071 | 0.340 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2015 | 103 | 0.330 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 39 | 0.320 |
Why?
|
| Male | 31 | 2025 | 27749 | 0.320 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 69 | 0.310 |
Why?
|
| Infant, Newborn | 13 | 2025 | 1284 | 0.300 |
Why?
|
| Thoracoscopy | 3 | 2004 | 23 | 0.290 |
Why?
|
| Female | 29 | 2025 | 30726 | 0.280 |
Why?
|
| Laparoscopes | 1 | 2007 | 24 | 0.280 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.280 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 7 | 0.280 |
Why?
|
| Intussusception | 1 | 2007 | 10 | 0.280 |
Why?
|
| Choristoma | 1 | 2007 | 22 | 0.280 |
Why?
|
| Stomach | 1 | 2007 | 83 | 0.270 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 122 | 0.270 |
Why?
|
| Spleen | 2 | 2012 | 479 | 0.260 |
Why?
|
| Sternum | 1 | 2006 | 27 | 0.260 |
Why?
|
| Thoracic Wall | 1 | 2006 | 17 | 0.260 |
Why?
|
| Sutures | 2 | 2016 | 35 | 0.250 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 141 | 0.250 |
Why?
|
| Anus, Imperforate | 1 | 2005 | 4 | 0.250 |
Why?
|
| Catheterization, Central Venous | 2 | 1997 | 84 | 0.250 |
Why?
|
| Urethral Diseases | 1 | 2005 | 12 | 0.250 |
Why?
|
| Urinary Fistula | 1 | 2005 | 16 | 0.240 |
Why?
|
| Colonic Diseases | 1 | 2005 | 33 | 0.240 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.240 |
Why?
|
| Rectal Fistula | 1 | 2005 | 20 | 0.240 |
Why?
|
| Occupational Stress | 1 | 2025 | 19 | 0.240 |
Why?
|
| Urethra | 1 | 2005 | 63 | 0.240 |
Why?
|
| Occupational Injuries | 1 | 2025 | 33 | 0.230 |
Why?
|
| Ergonomics | 1 | 2025 | 78 | 0.230 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 1507 | 0.210 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 29 | 0.190 |
Why?
|
| Musa | 1 | 2021 | 7 | 0.190 |
Why?
|
| Hypocalcemia | 1 | 2022 | 16 | 0.190 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.190 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 6 | 0.190 |
Why?
|
| Stomach Volvulus | 1 | 2001 | 3 | 0.190 |
Why?
|
| Splenic Diseases | 1 | 2001 | 15 | 0.190 |
Why?
|
| Intestinal Atresia | 1 | 2001 | 2 | 0.190 |
Why?
|
| Duodenal Obstruction | 1 | 2001 | 4 | 0.190 |
Why?
|
| Common Bile Duct | 1 | 2001 | 19 | 0.190 |
Why?
|
| Esophageal Atresia | 2 | 2004 | 9 | 0.190 |
Why?
|
| Length of Stay | 4 | 2015 | 776 | 0.180 |
Why?
|
| Boston | 1 | 2022 | 247 | 0.180 |
Why?
|
| Postoperative Complications | 4 | 2025 | 1204 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 2338 | 0.180 |
Why?
|
| Physician Assistants | 1 | 2020 | 35 | 0.180 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 112 | 0.170 |
Why?
|
| Pediatricians | 1 | 2020 | 50 | 0.160 |
Why?
|
| Pediatrics | 1 | 2021 | 241 | 0.160 |
Why?
|
| Lung | 1 | 2004 | 920 | 0.150 |
Why?
|
| Appendix | 1 | 2018 | 13 | 0.150 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.150 |
Why?
|
| Hospital Mortality | 2 | 2013 | 842 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2018 | 48 | 0.150 |
Why?
|
| Fibroblasts | 2 | 1997 | 377 | 0.150 |
Why?
|
| Phytotherapy | 1 | 2018 | 52 | 0.140 |
Why?
|
| Hypertension, Renal | 1 | 1997 | 4 | 0.140 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1997 | 6 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 122 | 0.140 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1997 | 15 | 0.140 |
Why?
|
| Parenteral Nutrition | 1 | 1997 | 21 | 0.140 |
Why?
|
| Pharynx | 1 | 1997 | 21 | 0.140 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 23 | 0.140 |
Why?
|
| Hematoma | 1 | 1997 | 68 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2018 | 163 | 0.130 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 76 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 483 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2382 | 0.130 |
Why?
|
| Blood Proteins | 1 | 1996 | 76 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2018 | 458 | 0.130 |
Why?
|
| Esophagostomy | 1 | 1996 | 1 | 0.130 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1996 | 20 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 409 | 0.120 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 67 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 1996 | 54 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 132 | 0.120 |
Why?
|
| Postoperative Care | 1 | 1996 | 115 | 0.120 |
Why?
|
| Pancreas | 1 | 2015 | 146 | 0.120 |
Why?
|
| Kidney | 1 | 1997 | 414 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 931 | 0.120 |
Why?
|
| Age Factors | 3 | 2013 | 1504 | 0.110 |
Why?
|
| Incidence | 3 | 2013 | 1238 | 0.110 |
Why?
|
| Drainage | 2 | 2011 | 150 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2013 | 7 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2013 | 746 | 0.110 |
Why?
|
| Soft Tissue Infections | 2 | 2011 | 45 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 628 | 0.100 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 52 | 0.100 |
Why?
|
| Community-Acquired Infections | 2 | 2011 | 92 | 0.100 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 4 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.100 |
Why?
|
| Firearms | 1 | 2013 | 54 | 0.100 |
Why?
|
| Pain, Postoperative | 2 | 2025 | 141 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 23 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 46 | 0.100 |
Why?
|
| Neutropenia | 1 | 2012 | 62 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1479 | 0.100 |
Why?
|
| Rectum | 2 | 2005 | 86 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 241 | 0.090 |
Why?
|
| Equipment Design | 2 | 2007 | 329 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 349 | 0.090 |
Why?
|
| Appendectomy | 2 | 2018 | 49 | 0.090 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 19 | 0.090 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 43 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 49 | 0.090 |
Why?
|
| Ureteroscopy | 1 | 2011 | 6 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 486 | 0.090 |
Why?
|
| Operating Rooms | 1 | 2011 | 55 | 0.090 |
Why?
|
| Esophagus | 2 | 2004 | 50 | 0.090 |
Why?
|
| Emergencies | 1 | 2011 | 110 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 91 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 62 | 0.090 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 2516 | 0.090 |
Why?
|
| Acute Disease | 1 | 2012 | 658 | 0.090 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2010 | 12 | 0.080 |
Why?
|
| Surgical Stapling | 1 | 2010 | 12 | 0.080 |
Why?
|
| Gastroscopy | 1 | 2010 | 20 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 167 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2010 | 29 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1559 | 0.080 |
Why?
|
| United States | 5 | 2022 | 7426 | 0.080 |
Why?
|
| Splenectomy | 2 | 2012 | 41 | 0.070 |
Why?
|
| Bacteriuria | 1 | 2007 | 11 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 86 | 0.070 |
Why?
|
| Adult | 7 | 2025 | 15681 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2005 | 27 | 0.060 |
Why?
|
| Wound Healing | 2 | 2016 | 174 | 0.060 |
Why?
|
| Funnel Chest | 1 | 2005 | 7 | 0.060 |
Why?
|
| Gynecomastia | 1 | 2005 | 11 | 0.060 |
Why?
|
| Prostatic Diseases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2005 | 45 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 1 | 2005 | 14 | 0.060 |
Why?
|
| Urinary Catheterization | 1 | 2005 | 19 | 0.060 |
Why?
|
| Colostomy | 1 | 2005 | 23 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 602 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 735 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 21 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 75 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 20 | 0.060 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2007 | 3067 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2005 | 47 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 26 | 0.060 |
Why?
|
| Operative Time | 1 | 2025 | 76 | 0.060 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.060 |
Why?
|
| Insufflation | 1 | 2004 | 8 | 0.060 |
Why?
|
| Animals | 4 | 2016 | 19650 | 0.060 |
Why?
|
| Pressure | 1 | 2004 | 76 | 0.050 |
Why?
|
| Hand Injuries | 1 | 2003 | 11 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 221 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 354 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 41 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 77 | 0.050 |
Why?
|
| Fundoplication | 1 | 2002 | 18 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 29 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 410 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 33 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 902 | 0.050 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 11 | 0.050 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2022 | 4 | 0.050 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 8 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 10 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2022 | 31 | 0.050 |
Why?
|
| Cisplatin | 1 | 2002 | 119 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2002 | 97 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 25 | 0.050 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2001 | 24 | 0.050 |
Why?
|
| Mouth Diseases | 1 | 2001 | 13 | 0.050 |
Why?
|
| Airway Obstruction | 1 | 2001 | 37 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2022 | 79 | 0.050 |
Why?
|
| Laparotomy | 1 | 2001 | 47 | 0.050 |
Why?
|
| Cysts | 1 | 2001 | 40 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2015 | 814 | 0.050 |
Why?
|
| Urogenital System | 1 | 2001 | 3 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 1234 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2013 | 1925 | 0.050 |
Why?
|
| Cesarean Section | 2 | 2001 | 95 | 0.040 |
Why?
|
| Fetus | 2 | 2001 | 93 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 516 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 276 | 0.040 |
Why?
|
| Birth Injuries | 1 | 1998 | 2 | 0.040 |
Why?
|
| Rectovaginal Fistula | 1 | 1998 | 3 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 6 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 24 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 10 | 0.040 |
Why?
|
| Cytotoxins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 402 | 0.040 |
Why?
|
| Rhodiola | 1 | 2018 | 15 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 40 | 0.040 |
Why?
|
| Rectal Diseases | 1 | 1998 | 27 | 0.040 |
Why?
|
| Vagina | 1 | 1998 | 79 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 546 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1997 | 18 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 423 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 102 | 0.030 |
Why?
|
| Collagen | 1 | 1997 | 115 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2010 | 98 | 0.030 |
Why?
|
| Esophageal Achalasia | 1 | 1997 | 28 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 192 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 559 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1996 | 2 | 0.030 |
Why?
|
| Exercise | 1 | 2003 | 883 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 11 | 0.030 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1996 | 4 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1996 | 20 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1996 | 29 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 178 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 692 | 0.030 |
Why?
|
| Gestational Age | 1 | 1996 | 178 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 2375 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 101 | 0.030 |
Why?
|
| Ischemia | 1 | 1997 | 199 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2050 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 229 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1368 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 941 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 619 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 914 | 0.030 |
Why?
|
| Young Adult | 2 | 2013 | 4272 | 0.020 |
Why?
|
| Urban Population | 1 | 2013 | 180 | 0.020 |
Why?
|
| Cell Line | 1 | 1996 | 1983 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 554 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 2055 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 283 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 742 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 244 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 249 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 935 | 0.020 |
Why?
|
| Clavulanic Acids | 1 | 1989 | 2 | 0.020 |
Why?
|
| Ticarcillin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Clindamycin | 1 | 1989 | 13 | 0.020 |
Why?
|
| Penicillins | 1 | 1989 | 29 | 0.020 |
Why?
|
| Gentamicins | 1 | 1989 | 23 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 215 | 0.020 |
Why?
|
| Retreatment | 1 | 2009 | 46 | 0.020 |
Why?
|
| Middle Aged | 2 | 2025 | 16314 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1989 | 140 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2005 | 37 | 0.020 |
Why?
|
| Mastectomy, Simple | 1 | 2005 | 2 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 131 | 0.010 |
Why?
|
| Sus scrofa | 1 | 2004 | 27 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 242 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 169 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 107 | 0.010 |
Why?
|
| Accidents, Home | 1 | 2003 | 9 | 0.010 |
Why?
|
| Contracture | 1 | 2003 | 8 | 0.010 |
Why?
|
| Finger Injuries | 1 | 2003 | 12 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 85 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 13408 | 0.010 |
Why?
|
| Pregnancy | 2 | 2001 | 2213 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 155 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 526 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 82 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2001 | 6 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2001 | 42 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 39 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 108 | 0.010 |
Why?
|
| Circumcision, Male | 1 | 2001 | 8 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 55 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2002 | 180 | 0.010 |
Why?
|
| Massachusetts | 1 | 2005 | 2019 | 0.010 |
Why?
|
| Breech Presentation | 1 | 1998 | 1 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1998 | 228 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 145 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 34 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1998 | 163 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 472 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 170 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1997 | 365 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 495 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1998 | 523 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 4986 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 1137 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1997 | 2092 | 0.010 |
Why?
|
| Abdomen | 1 | 1989 | 91 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 451 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1989 | 678 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 5119 | 0.000 |
Why?
|